Electromed Inc. (ELMD) Insider Trading

Last 12 months

Insiders sold $2.2M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Kathleen Skarvan sold $1.42M on May 15, 53% of their stake, outside a plan. The last open-market buy by an executive or director was in Mar 2024.

Net open-market

−$2.2M

0 buys · 3 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 3

executives and directors

Last open-market buy

Mar 2024

Mar 1, 2024

Get an email when ELMD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 8	James L. Cunniff CEO and President	SoldNo plan 3 parts	9,700	$36.51 average	$354k	6.2%	Form 4
Jun 4	Bradley M. Nagel Chief Financial Officer	SoldNo plan 2 parts	11,801	$36.35 average	$429k	38%	Form 4
May 15	Kathleen Skarvan Director	SoldNo plan 4 parts	40,000	$35.48 average	$1.42M	53%	Form 4
Sep 10, 2025 – Sep 11, 2025	Andrew Summers Director	SoldNo plan 5 parts	65,714	$24.32 average	$1.6M	19%	Form 4
Feb 20, 2025 – Feb 24, 2025	Andrew Summers Director	SoldNo plan 9 parts	111,475	$27.99 average	$3.12M	19%	Form 4
Feb 14, 2025 – Feb 18, 2025	Kathleen Skarvan Director	SoldNo plan 5 parts	76,583	$30.48 average	$2.33M	70%	Form 4
Dec 5, 2024	Andrew Summers Director	SoldNo plan 6 parts	37,404	$28.15 average	$1.05M	7.6%	Form 4
Dec 2, 2024 – Dec 4, 2024	Andrew Summers Director	SoldNo plan 7 parts	65,630	$30.12 average	$1.98M	12%	Form 4
Nov 18, 2024 – Nov 19, 2024	Kathleen Skarvan Director	SoldNo plan 3 parts	150,000	$28.01 average	$4.2M	65%	Form 4

Jun 8No plan
James L. Cunniff
CEO and President · sold 9,700 at avg $36.51
$354k
6.2% of stake
Jun 4No plan
Bradley M. Nagel
Chief Financial Officer · sold 11,801 at avg $36.35
$429k
38% of stake
May 15No plan
Kathleen Skarvan
Director · sold 40,000 at avg $35.48
$1.42M
53% of stake
Sep 10, 2025 – Sep 11, 2025No plan
Andrew Summers
Director · sold 65,714 at avg $24.32
$1.6M
19% of stake
Feb 20, 2025 – Feb 24, 2025No plan
Andrew Summers
Director · sold 111,475 at avg $27.99
$3.12M
19% of stake
Feb 14, 2025 – Feb 18, 2025No plan
Kathleen Skarvan
Director · sold 76,583 at avg $30.48
$2.33M
70% of stake
Dec 5, 2024No plan
Andrew Summers
Director · sold 37,404 at avg $28.15
$1.05M
7.6% of stake
Dec 2, 2024 – Dec 4, 2024No plan
Andrew Summers
Director · sold 65,630 at avg $30.12
$1.98M
12% of stake
Nov 18, 2024 – Nov 19, 2024No plan
Kathleen Skarvan
Director · sold 150,000 at avg $28.01
$4.2M
65% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ELMD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Electromedical & Electrotherapeutic Apparatus

EDAPEdap Tms SA

VASOVaso Corporation

IRIXIridex Corporation

CBLLCeribell, Inc.

FONRFonar Corp

BLFSBiolife Solutions Inc.

ZYXIQZynex Inc

ECORElectroCore, Inc.

Spot a number that looks wrong? Check it in ELMD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ELMD

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.